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Infective and anti-infective properties of breastmilk 
from HIV-1 -infected women 
PHILIPPE VAN DE mRRE ARLETTE SIMONON DEO-GRATIAS HITIMANA 
JEAN-BAPTISIE BUTERA &RS"wW VAN GOETHEM 
FRANÇOIS DABIS PHILIPPE MSELLATI BARBARA MUKAMABANO 
ETIENNE KARITA 
Human immunodeficiency virus type 1 (HIV-1) 
is transmitted mainly by cell-to-cell contact. We 
postulated that transmission of HIV-1 through 
breastmilk could be favoured by the presence of 
infected cells, by deficiency of anti-infective 
substances in breastmilk, or both factors. 
21 5 HIV-1 -infected women were enrolled at 
delivery in Kigali, Rwanda; milk samples were 
collected 15 days, 6 months, and 18 months post 
'partum. HIV-1 IgG, secretory IgA, and IgM were 
assayed by western blot, for the latter two after 
removal of IgG with protein G. In the 15-day and 
6-month samples, we sought viral genome in milk 
cells by a double polymerase chain reaction with 
three sets of primers (gag, pol, and em). HIV-1 
infection in the offspring was defined according to 
serological and clinical criteria. At 15 days, 6 
months, and 18 months postpartum, HIV-1 specific 
IgG was detected in 95%, 98%, and 97% of 
breastmilk samples, IgA in 23%, 28%, and 41 %, and 
IgM in 66%, 78%, and 41%. In children who 
survived longer than 18 months, the probability of 
infection was associated with lack of persistence of 
IgM and IgA in their mothers' milk (adjusted xz for 
trend, p=O.O1 for IgM and p=0.05 for IgA). The 
presence of HIV-I -infected cells in the milk 15 days 
post partum was strongly predictive of HIV-1 
infection in the child, by both univariate (p<0.05) 
and multivariate analysis (p=O.OI ). The 
combination of HIV-1 -infected cells in breastmilk 
and a defective IgM response was the strongest 
predictor of infection. 
HIV-1 infection in breastfed children born to 
infected mothers is associated with the presence of 
integrated viral DNA in the mothers' milk cells. IgM 
and IgA anti-HIV-I in breastmilk may protect 
against postnatal transmission of the virus. 
Lancei 1993; 341 : 91 4-1 8. 
Introduction 
Postnatal mother-to-child transmission of human 
immunodeficiency virus type 1 (HIV-1) is well recognised.: 
In Rwanda, the estimated rate of HIV-1 transmission from 
mothers who acquired infection post parturn to their irifants ' 
ranged from 25% to 53%.2 This high risk of HIWI 
transmission has been atuibuted to the high viral burden in 
primary infecti~n.~ In some cohorts of children bom to 
HIV-1-infected women in developed countries, the 
probability of infection was higher for breaded infants than 
for bottle-fed infants.J5 However, rhese observational 
studies were not designed to estimate the excess risk of 
transmission attributable to posmatal transmission from 
PHILIPPE LEPAGE 
women who had been infected before delivery, a problem 
that remains unsolved. The biological properties of milk 
from HIV-1-infected women have not been fully studied. 
Two reports have described the detection of HIV-1 
antibodies of IgG, IgA, and IgM classes in breastmilk 
samples from infected Both sample sizes were too 
small for any conclusion about possible effect of these 
antibodies on the transmission of HIV-I to infants to be 
drawn. 
Many animal retroviruses, like human T-cell leukaemia 
virus type 1, are mainly transmitted by cell-to-cell contacts." 
We therefore postulated that posmatal transmission of 
HIV-I through breastmilk, if it occurs, should be favoured 
by the presence in breastmilk of infected cells and deficiency 
of anti-infective substances such as specific antibodies. We 
report hereour study of-sequential breastmilk samples from 
215 HIV-I-infected mothers in Kigali, Rwanda. 
Subjects and methods 
A prospective cohort study on perinatal transmission of HIV-I 
srarted in Kigali, the capiral of Rwanda, in Novanber, 1988. A11 
women giving birth at the maternity ward of the Cenue Hospiraher 
de Kigali (CHK) were told by social workers of the objzcrves, 
constraints, and advantages of the study. Verbal consent was 
obtained from each woman who agreed to take part. 215 HIV-I 
seropositive mothers and 217 seronegative mothers were enrolled 
with their newborn infants. Details of enrolment procedGres are 
given el~ewhere.~ We concentrate in this paper on mother-infant 
pairs seropositive at the time of delivery. 
After delivery, enrolled families were visited every 2 weeks by 
social workers, who collected information on the health of the 
children by means of standard questionnaires, T h e  children and 
their mothers were examined by a physician every 3 months. When 
necessary, children were seen h the outpatient ch.ic or admined to 
the CHK, and treated free of charge. At study entry none of the 
HIV-I-seropositive mothers met the World Health Organisation 
(WHO) clinical case-definition of acquired immunodeficiency 
syndrome (AIDS)." Except for histories of herpes zoster infection 
(reported in 9) and chronic cough, the frequency of signs and 
symptoms did not differ between HIV-1 seropositive and 
seronegative mothers. 
Criteria used to classify children of seropositive mothers as 
infected with HIV-1, not infected, or with indeterminate status are 
drawn from a working group consensus on mother-to-child 
transmissionofHIV.llJz The use ofthis classification is restricted to 
children who had reached or could have reached the age of 15 
months by the h e  of analysis. I t  takes into account the HIV-1 
antibody status at 15 months and, if the child died before that age, 
the presence or absence of signs and symptoms. A child was taken to 
be HIV infected if he or she had AIDSi3 at whatever age, died of an 
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TABLEI-NUMBERSOFMlLKANDBLOODSAMPLESAVAlLABLE 
AT EACH TESTING POINT 
- 
Mothers followed in cohorr* 
lactating women 
Blood sample available for CD4JCD8 
festing 
Milk samples tested: 
W Month Month 
15 6 18 
210 195 151 
208 184 119 
188 ND ND 
By PCR 129 96 ND 
For IgG anti-HIV-1 176 153 104 
For IgA anti-HIV-1 162 142 95 
For IgM and-HIV-1 16.3 153 85 
*Total enrolled minus those los110 follow-up. those who had died, and those whose 
babies had died. 
ND=notdona 
HIV-related cause, or was HIV-antibody positive at 15 months. A 
child was taken as not infected with HIV if he or she was 
HIV-antibody negative at 15 months or was lost to follow-up or 
died of an HIV-unrelated cause and was HIV-antibody negative at 
9 months or beyond. All other children are classified as of 
indeterminate status. 
Every 3 months, blood samples were taken from mothers and 
children. Serum samples were screened by an enzyme-linked 
immunoassay (Vironostika, Organon Teknika, Boxtel, 
Netherlands). All positive samples were continned by western blot 
(Du Pant, Wilmington, Delaware, USA). 15 days postpartum, a 10 
mL blood sample was obtained from the mothers. Mononuciear- 
cell subpopulations were quantified by means of an indirect 
immunofluorescence technique and monoclonal antibodies. A 
CD4/CD8 ratio below 0.5 was taken as the criterion for severe 
immunodeficiency. 
Weaskedeachlactatingmotherfor IO-15mL breastmilk 15 days, 
6 months, and 18 months post partum. Milk samples were 
immediately centrifuged at 300g. The lipid layer was removed with 
a pipeae and lactoserum was stored at - 20°C until testing. Cell 
pellets were washed twice in Coon’s solution containing 1% bovine 
semm albumin, then stored at - 70°C. 
Milk HIV-l IgG antibodies were detected by means of a 
standard western blot test (Novapath, Bio-Rad, Hercules, 
California, USA). Specific IgM antibodies were assayed by western 
blot with the avidin-horseradish peroxidase system (anti-IgM 
conjugate, u-chain specilic, diluted 1 in 500, Sigma 
Immunochemicals, Deisenhofen, Germany) and strips from 
OrganonTeknika. Milk IgA antibodies were tested by western blot 
(Bio-Rad), by means of an anti-human-IgA, a-chain specific, 
alkaline-phosphatase conjugate diluted 1 in 500 (Sigma). This 
conjugate is most suitable for detection of secretory IgA. For each 
antibody test, the sample dilution used was 1 in 100. To improve the 
specificity and sensitiviv of specific IgM and IgA detection, 
western blots were done after treaunent of lactosenun samples with 
Sruphylococcus LZ~YUS protein G (Pansorbii and Sansorbii, 
Calbiochem Corporation, La Jolla, California, USA) to remove 
IgG.6,14 No residual IgG was detected by radial immunodiffusion 
(Norpardgen IgG, Behring, Marburg, Germany)‘s after this 
process. To ensure spedficity, western blot assays were repeated on 
a subset of lactoserum samples positive for HIV-l IgM, IgA, or 
both, after preincubation with serial dilutions of specific goat 
antibodies to human u chain or a chain and demonstration of 
progressive inhibition of HIV-l antibody detection by western 
blot.14 For the detection of specific IgM and IgA antibodies, a 
positive sample was required to have reactive bands corresponding 
to HIV-l ~2.4 (major nucleocapsid protein), gp 120/160 (major 
envelope glycoprotein), or both, with or without additional 
bands.6 
DNA from the mononuclear cells pelleted from the milk samples 
was exuacted* and a double PCR was done with three pairs of 
HIV-l-specific oligonucleotide sequences in the gag, env, and pal 
regions of the HIV-l genome.2 As well as known negative controls, 
internal controls were included in each PCR run; these were W 
DNA samples extracted from cell pellets of milk samples collected 
in HIV-1-seronegative mothers from the comparative cohort (13 at 







IgG IgA IgM PCR 
Monlh 6 
Time post partum 
IgG IgA IgM 
Month 18 
Detection of HIV-1 antibodies of IgG, IgA, and IgM classes and 
HIV-l -infected cells by PCR in milk samples. 
Vertical bars = 95% Cl 
positive when at least two of the three primer pairs gave a detectable 
signal. 
The Mantel-Haenszel x2 test, MacNemar test, adjusted and 
unadjusted x2 test for linear trend, two-tailed Fisher’s exact test, and 
Student’s I test were used for comparisons, with a significance level 
of 0.05. Unadjusted and Mantel-Haenszel weighted odds ratios 
were calculated to measure the suength of association when 
appropriate,‘6 and rheir 95% CI were calculated by the Cornfield 
method. Exaa confidence limits were also calculated when 
necessary. Finally, we constructed a multivariate logistic regression 
model in an attempt to explain the HIV-l infection status of the 
children, which included maternal age, parity, history of adverse 
pregnancy outcome, maternal clinical status at delivery, method of 
delivery, sexually transmitted diseases diagnosed at the time of 
delivery, presence or absence of infected cells in milk by PCR 15 
days post partum, persistence of HIV-l IgM up to 18 months (3 
positive samples r~ less than3), and the mother’s CD4/CD8 ratio 15 
days post partum. 
Results 
46 (21.1%) of the 218 children born to HIV-1-Gected 
mothers were classified as HIV-l infected, 140 (642%) as 
not infected, and 32 (14.7%) as indeterminate status. 
15 days after delivery 72% of 188 HIV-1-seropositive 
mothers had CD4/CD8 ratios below 1.0, including 24% 
who had ratios below OS8 The proportion of mothers who 
gave milk samples was 85% on day 15,83% at 6 months, 
and 87% at 18 months (table I). In some cases there was not 
enough lactoserum for us to do all three serological tests, but 
there was no difference in HIV-1 status between children 
whose mothers’ milk was and was not tested. 47 (27%) of 
176 samples collected at day 15 and 57 (37%) bf 153 
collected at month 6 had insi$icient milk or insufficient 
TABLE II-HIV-1 INFECTION STATUS OF CHILDREN WHO 
SURVIVED LONGER THAN 18 MONTHS AND PERSISTENCE OF 
MILK HIV-l IGM 
Milk samples Mantel-Haenszel 
with anti- HIV-1 -infected HIV-l -uninfected weighted odds 
HIV-1 lgM* infants infants ratio (95% Cl) 
0 6 103 
1 
2 
11 0~90(0~08-10-1) ,’ 
2 .7 21 0.28 (044-l-89) 
3 3 25 0.16 (0.02-1.17) ‘. 
TOtal 21 63 .‘. ‘;. . . 
*Maximum 3, since milk was collected at day 15. month 6. and month 18. 
916 
Test results on milk samples 
collected at day 15 
PCR IgM 
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Child‘s HIV-1 status Mantel-Haenszel 
Transmission rate (%) weighted odds ratio 
Infected Not infected Indeterminate (95% CI)’ (95% CI)* 
11 51 7 18 (S-28) 1-00 
8 19 6 30 (13-47) 2.35 (O 66-8.34) 
9 10 1 47 (2269) 4 51 (1.09-18.96) 
28 80 14 26 118-34) 
TABLE III-RELATION OF HIV-1 INFECTION STATUS OF 
CHILDREN TO PRESENCE OF HIV-1-INFECTED CELLS IN 
BREASTMILKATDAY 15 
Child‘s HIV-1 status 
32 (53%) 9 (1.5%) 
83 (64%) 16 (13%) 
51 (74%) 7 (10%) 
cells for PCR. However, there was no difference in 
CD4/CD8 ratio between mothers whose milk was or was 
not tested by PCR at day 15 (mean 0.77 [SD 0-491 vs 0.82 
[0-56], p=O57). Similarly, there was no difference in 
distribution of HIV-1 infection status between children 
bom to mothers with and without PCR done on milk 15 
days post p a r ”  (xz test, p ~0.81).  
At each collection time, the most frequently detected 
immunoglobulin class for specific anti-HIV-1 in breastmilk 
samples was IgG (figure). Igh4 was the next most common, 
and IgA was found less often. The frequency of a positive 
PCR declined from 47% at 15 days to 21% at 6 months 
(Mac” test for 65 paired samples, p cO.01). 
The detection of specific IgM in milk samples 15 days 
post partum was not related to the immune status of the 
mothers. The mean CD41CD8 ratio in 105 mothers with 
milk samples positive for HIV-1 IgM was 0.78 (0.52) 
compared with 0.70 (0.43) in 48 mothers with milk samples 
negativeforHIV-1 IgM(Student’sttest,p=0.36).Norwas 
the detection of HIV-1 IgA at 15 days associated with the 
mother’s immune status (CD4/CD8=0.82 [O521 zts 0.73 
[0.43] in 35 IgA-positive and 115 IgA-negative mothers, 
respectively; p=O.38). Similarly, we found no relation 
between the likelihood of HIV-1 infection in the children 
and the detection of HIV-1 IgM or IgA at any collection 
h e .  Among 115 children fed with breastmilk containing 
HIV-1 IgM at day 15,23 (20%) were HIV-1 infected, 75 
(65%) not infected, and 17 (15%) of indeterminate status 
compared with 14 (26%), 37 (70%), and 2 (4%), 
respectively, among the 53 children fed with breastmilk not 
containing IgM (Mantel-Haenszel xz adjusted for mother’s 
immune status, p = 068; Mantel-Haenszel weighted odds 
We assessed the relation between HIV-I infection status 
of the children and the number of milk samples positive for 
HIV-1 IgM and IgA by means of a trend analysis. By 
de f~ t ion ,  this analysis could include only the 84 children 
who lived beyond the age of 18 months and whose mothers 
provided the laboratory with all three milk samples. The 
persistence of milk HIV-1 IgM antilxdies was linearly 
associated with the absence of HIV-1 infection in children 
(x” for trend, adjusted for mother’s immune status = 6.66, 
p=O.OI, table II). There was a similar, though weaker, 
association for the persistence of milk HIV-1 IgA (xz = 3.79, 
p = 0.05). 
ratio 0.76 [0.31-1.91]). 
TABLE IV-MULTIVARIATE ANALYSIS OF POTENTIAL RISK 
FACTORS FOR MOTHER-TO-CHILD TRANSMISSION OF HIV-1 
Odds ratio (95% CI) 
Positive PCR in day 15 milk sample 
CD4/CD8 rado < O 5  on day 15 
HIV-1 IgM in breasnnilk persisting 
matemal blood sample 3.45 (092-123) 
up to 18 months 
All 34 milk samples from HIV-1-seronegative mothers 
used as internal controls remained consistently unteactive 
by PCR. The detection of HIV-1-infected cells in the milk 
samples 15 days post partum was related to the immune 
status of the seropositive mothers; the mean CD4/CD8 ratio 
was 0.66 (0.43) in mothers with PCR-positive milk samples 
and 0-87 (0.53) in those with PCR-negative samples 
(Student‘s i test, p=O.O3). The detection of integrated 
DNA in milk cells 15 days post parmm was independent of 
the presence of HIV-1 IgA or IgM in milk (HIV-1 IgA and 
PCR, p=O.34; IgM and PCR, p=0.38, x2 test). The 
detection by PCR of infected milk cells at 15 days was 
associated with the subsequent development of HIV-I 
infection in the infants (odds ratio=2.75 [95% CI 1.07- 
7.161; table III). Adjustment for mother’s immune status 
and IgM results did not affect this association. By contrast, 
no association with HIV-1 infection in the child was found 
for PCR on milk samples collected at 6 months (p =0*21). 
Multivariate analysis was done on data for 63 children 
who survived more than 18 months (17 HIV-1 infected and 
46 not infected). A positive PCR in the milk sample collected 
15 days post parturn was the only factor significantly 
associated with transmission of HIV-1 from mother to 
infant (table IV). The relation of an inconsistent or 
non-persistent IgM anti-HIV-1 response in milk with 
transmission was of borderline significance. 
T o  verify our hypothesis that some infants coyld have 
been infected by ingestion of milk containing HIV-1- 
infected cells but with a defective Igh4 anti-HIV-1 
response, the distribution of infants’ HIV-I status was 
examined according to the presence of infected cells in 
15-day milk samples with or without HIV-1 IgM. This 
trend analysis was consistent with the proposed hypothesis, 
even after control for the mother’s immune status (adjusted 
xz for trend = 6.28, p = 0.01, table v). The association was 
not affected by use of extreme assumptions; if all 14 children 
of indeterminate HIV-1 infection status were taken as not 
infected p is 0.01, and if they are all taken as infected p is 
0.02. Thus, in children fed with early breastmilk containing 
HIV-1-infected cells but lacking specific IgM antibodies, 
the likelihood of being infected was 47%, which was 
significantly higher than that for children fed breastmilk 
without KIV-1-infected cells (18%). In the latter subset of 
children, the presence or absence of specific IgM did not 
affect the risk of HIV-1 acquisition (4 infected children of 20 
. 
. 
’Transmission rates and odds ratios were calculated ty excluding children with indeterminate HIV-1 infectious status and adjusting for mother’s CD4/CD8 ratio. 
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fed PCR-negative/IgM-negative milk vs 7 of 42 fed 
PCR-negative/IgM-positive m i k  two-tailed Fisher’s exact 
test, p = 0.74; odds ratio = 1.25 [0.26-5.79]). 
Discussion 
This study describes the frequency and the timing of 
specific humoral responses against HIV-I in the milk of 
infected mothers and the relations to matemal-child 
transmission of HIV-I. Although it is based on qualitative 
measurements, several characteristics of the specific 
biological properties of breastmilk against HIV-I can be 
inferred. Secretory IgA antibodies are the main component 
of humoral immunity in brea~tmilk.’~ They probably 
protect against viral disease by coating and blocking viral 
attachment and by neutralisation of viral particles.18 By 
contrast with many other infectious diseases, specific HIV-1 
IgA in breastmilk was rarely detected in this study. Other 
body secretions, such as saliva1¶ and seminal flUid20 from 
HIV-infected subjects contain smaller amounts of HIV-I- 
specific and non-specific IgA than expected, which may 
reflect impairment of mucosal immunity. Usually colostrum 
and early breastmilk contain large amounts of IgA, which 
steadily decline during the first few months of lactation. By 
contrast in our study, there was a progressive increase in the 
frequency of HIV-1 IgA. Defective synthesis of secretory 
IgA can be compensated for by secretory IgM (IgM 
antibodies with a secretory component).zl Indeed, in many 
cases we found sustained humoral responses against HIV-1 
of the IgM type. We did not test for HIV-1 IgA and IgM in 
the blood samples of our HIV-I-infected mothers. 
However, in a previous study, these antibodies were not 
detected in the serum samples of mothers with milk samples 
positive for IgA, IgM, or both; this fmding suggests that 
most of the IgA and IgM antibodies detected in milk are 
synthesised within the mammary gland.zz 
Our study was l i i t e d  by a major methodological 
difficulty. Because there are no diagnostic tools to determine 
HIV infection status of newborn infants with an acceptable 
level of confidence, we could not distinguish in-utero 
infections from those acquired during or after birth. 
Consequently, we had to refer to an overall risk of 
transmission of HIV from mother to child. 
HIV-I-infected cells were found by double PCR in many 
breastmilk samples from HIV-1-infected mothers collected 
early in the lactation period. The frequency of detection 
declined with the duration of lactation, which is consistent 
with the striking decline in the cell contents of breastmilk 
during the first 8 weeks of lactati0n.2~ We should emphasise 
that integrated segments of viral DNA detected by PCR do 
not necessarily represent infectious virus, since defective 
integrated virus could be identified by this extremely 
sensitive method. We found PCR-positive breastmilk 
samples more frequently in mothers with severe immune 
deficiency than in those who were immunocompetent. 
However, the presence of HIV-I-infected cells in early 
breastmilk was associated with HIV-1 infection in the child, 
independently of the mother’s immune status. By 
multivariate analysis, the presence of infected cells in 
breastmilk was the factor most strongly associated with 
HIV-1 transmission to children of HIV-1-infected mothers 
who survived more than 18 months. This factor was even 
more strongly associated with transmission than the 
mother’s immune status, a variable already shown to be 
related to transmission when applied to the entire cohort in 
the same study12 and in others.” Two smaller s t u d i e ~ ~ ” ~  
have found associations between the detection of integrated 
viral DNA in cells from breastmilk and mother-to-child 
transmission of the virus.u25 Such observations are 
consistent with the posmatal transmission of many human 
and animal retroviruses, which can be passed from mother 
to offspring by infected macrophages and lymphocytes in 
milk.’ For bovine leukaemia virus, as few as 2000 infected 
cells can transmit the infection.z6 Our fmding of no 
association benveen the presence of infected milk cells in 
6-month samples and mother-to-infant transmission 
suggests that most of the cases of posmatal transmission 
through breastfeeding occur early in lactation if the mother 
has been infected before delivery. 
Our study suggests that VIV-1 IgM in breastmilk could 
be protective against posmatal transmission of the virus. 
There are several possible explanations of this effect. First, 
secretory IgM could compensate for a defective secretory 
IgA response and behave in a similar way by directly coating 
viral particles. Second, IgM antibodies are strong 
potentiators of complement-mediated cytotoxicity because 
of their high content of Fc sites. At least nine components of 
the complement system have been identified in human 
milk.I7 These components could have powerful lytic 
properties against HIV-1 virionz7 and, perhaps, against 
HIV-I-infected cells in association with specific IgM.Z8 
Third, as shown for murine sarcoma virus, specific IgM 
could take part in the lysis of infected cells by a mechanism of 
antibody-dependent lymphocyte cyt0toxicity.2~ 
We did not aim to quantify the risk of transmission of 
HIV-1 through breastfeeding nor to fmd out when HIV 
infection occurred. Indeed, some of the children who were 
assumed to have been infected posmatally could well have 
been infected before birth. Our study suggests that some 
biological factors in milk are associated with mother-to- 
child transmission and that others seem to protect against 
infection. The consistency of our biological model, the 
strength of the associations documented, and their biological 
plausibility suggest that these factors are indeed 
determinants of transmission and not intermediate or 
confounding variables. The results of this study shculd not 
be interpreted as a promotion of formula feeding. The 
recent recommendations of the WHO and U N I C E F  on 
the promotion of breastfeeding remain valid and are 
certainly not questioned by our findings. 
In our cohort, children fed with early breastmilk without 
HIV-1-infected cells had a low risk of acquisition of HIV-1 
from their mothers. In these children, the rate of 
transmission is similar to that estimated in infants in 
countries where formula feeding by HIV-infected mothers 
is almost the r ~ l e . ~ 5  On the other hand, children fed with 
breastmilk containing HIV-I-infected cells but not HIV-1- 
specific IgM had a very high risk of infection (47%). Our 
study seems to validate a model for the pathogenesis of 
HIV-I acquisition by breastfeeding in which infected cells 
confer a risk of transmission q a t  could be circumvented by 
the local production of specific IgM with cytotoxic . 
properties, neutralising properties, or both. Our findings 
indirectly suggest that a vaccine preparation inducing a 
persistent immune response of the IgM type in the mother’s 
body fluids could be valuable to prevent transmission of 
HIV-1 from mother to child. Such hypotheses require 
confirmation before specific interventions are developed 
and tested in populations with greatest need, namely women 
living in developing countries with high prevalence and 
inddence of HIV infection. 
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From The Lancet 
Giving a specimen 
Expert seminologists in this counuy are still scarce, and their 
knowledge has so far not permeated the vast bulk of clinicians and 
pathologists called in to report on the fertilising power of a given 
specimen of semen. It is not suf5cient to glance down a microscope 
and repon no sperms, sperms in plenty, mobile sperms, or sperms 
dead: in many cases these are false readings and the patient 
is misdiagnosed, ofren with serious consequences to F t a l  
equilibrium. The examination of the male in a case of sterility 
consists of a careful clinical survey . . . . The patient's general 
physical condition and development is then assessed, constitutional 
and metabolic disorders being eliminated or investigated . . . . The 
next step is the urological examination of the extemal geniralia, 
prostate and vesicles, and the exclusion of congenital and acquired 
defects . . . . This is followed by the most imporrant single 
investigation, the examination of a specimen of semen. Semen can 
be collected by two methods, masnrbation or condom, and in each 
certain details must be observed or the specimen is vitiated. Both 
have inherent defects, and some men fmd considerable dittidty in 
obtaining either, but these obstacles can be overcome by the tactful 
cooperation of the doctor. A masturbation specimen must be 
collected in a clean dry wide-necked glass receptacle with a stopper. 
Theglassmust beclean, andforpreferenceoldandmuchusedsince 
new glass reacts injuriously on spermatoza; it must be dry because 
hypotonic solutions afim sperm viability. Such a specimen can be 
collected in or near the laboratory and be examined at once, and rhis 
is an advantage, but some nervous men fmd this methcd distasteful 
or impossible, and for them the condom must be used. An ordinary 
rubber condom is satisfactory provided it is thoroughly washed in 
running water and then dried on clean filter paper; the outside only 
should be powdered before re-rolling. Continence should be 
enjoined for a week before the producdon of the specimen, which 
should be obtained by ordinary coitus with as shorc a delay as 
possible before it is examined. After coitus it is best to transfer the 
contents of the condom to a glass container, and this is best done by 
snipping the end ofthe condom with scissors. If transpon takes rime 
the glass container should be kept cool-in a thermos flask of cold 
tap water-never warm, so it should not be put in that handy human 
incubatorthe waistcoat pocket. All these trivial details are imponant 
and can be best secured by issuing each patient with a small 
typesmpt card of instruction. 
(May 8 1943) 
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